Replies to post #804948 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

What you say you’ve been right about is still all open for debate.

ALT-DC may be DCVAX but should the UCLA-NWBO relationship sour (if it hasn’t already?), UCLA will likely continue on with their own “next gen” ALT-DC. All the rest is still open for debate.

>>I have been right about a lot. I was right about ATL-DC being DCVax-L three years ago and till this day I still take paid shills to school in the topic. I am right in the ORR endpoints debate. I am right in my debunking of the trial design, endpoint, external control FUD garbage critique. I was right about Linda Powers not having build Advent as a private self enrichment project.

[barnstormer]

Trying to predict dates on this company and stock is like throwing darts at a dartboard from 50 feet away. You may hit a few, but no one is going to hit a high score consistently.